시장보고서
상품코드
1441245

세계의 눈물샘용 기기 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 산업별 시장 규모, 점유율, 성장 분석 - 산업별 예측(2023-2030년)

Global Lacrimal Devices Market Size, Share, Growth Analysis, By Product(Intubation Sets, Stents And Tubes), By Application(Glaucoma, Dry Eye) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전 세계 눈물샘용 기기 시장 규모는 2022년 2,001억 6,000만 달러로 평가되었고, 예측 기간(2024-2031년) 동안 8.5%의 연평균 복합 성장률(CAGR)로 2023년 2,171억 7,000만 달러에서 2031년에는 4,171억 1,000만 달러로 성장할 것으로 예상됩니다.

눈물병 시장은 다양한 연령층에서 안과 질환에 대한 인식과 진단이 높아짐에 따라 큰 폭으로 성장하고 있습니다.

눈 관련 질환이 증가함에 따라 천자 플러그, 눈물주머니 스텐트, 관류 시스템 등 첨단 눈물주머니에 대한 수요가 증가하고 있습니다. 또한, 기술 및 수술 방법의 발전으로 환자 치료 결과가 개선되면서 시장 확대에 기여하고 있습니다. 인구 고령화와 이에 따른 노화와 관련된 안과 질환 증가도 시장의 지속적인 성장에 기여하고 있습니다. 의료 제공업체와 제조업체는 치료의 질과 환자 편의성 향상에 초점을 맞추고 진화하는 눈물샘용 기기 장애 환자의 요구를 충족시키는 혁신적인 솔루션을 개발하기 위해 적극적으로 노력하고 있습니다. 규제 요인과 상환 정책도 시장 역학을 형성하는 데 중요한 역할을 하고 있습니다. 전반적으로, 환자 중심의 솔루션과 치료 결과 개선에 점점 더 초점을 맞추고 있는 눈물 장치 시장은 안과 장비 부문의 기업들에게 유망한 기회를 제공합니다.

목차

주요 요약

  • 시장 개요
  • 번영과 쇠퇴

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 눈물샘용 기기 시장 : 제품별

  • 시장 개요
  • 삽관 세트
  • 스텐트 및 튜브
  • 확대기

세계의 눈물샘용 기기 시장 : 용도별

  • 시장 개요
  • 녹내장
  • 안구건조증
  • 눈물샘 염증

세계의 눈물샘용 기기 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • FCI Ophthalmic(프랑스)
  • Kaneka Corporation(일본)
  • Lacrimedics, Inc.(미국)
  • Cook Group(미국)
  • BVI(영국)
  • Rumex International(미국)
  • Bess Medical Technology GmbH(독일)
  • Alcon(스위스)
  • Bausch and Lomb Incorporated(미국)
  • BraunMelsungen AG(독일)
  • OASIS Medical, Inc.(미국)
  • Beaver-Visitec International(미국)
  • FC Optics Ltd.(이스라엘)
  • D.O.R.C. Dutch Ophthalmic Research Center(네덜란드)
  • OptiMedica Corporation(미국)
  • MicroSurgical Technology(미국)
  • Diamatrix Ltd.(영국)
  • FCI S.A.S.(프랑스)
  • Novartis AG(스위스)
  • Eye Kon Medical, Inc.(미국)
LSH 24.04.11

Global Lacrimal Devices Market size was valued at USD 200.16 Billion in 2022 and is poised to grow from USD 217.17 Billion in 2023 to USD Billion 417.11 by 2031, at a CAGR of 8.5% during the forecast period (2024-2031).

The lacrimal devices market is experiencing substantial growth due to the rising awareness and diagnosis of ophthalmic conditions across various age demographics.

With an increase in eye-related disorders, there is a growing demand for advanced lacrimal devices such as punctual plugs, lacrimal stents, and irrigation systems. Furthermore, advancements in technology and surgical methods have resulted in better patient outcomes, contributing to the expansion of the market. The aging population and the corresponding rise in age-related eye issues also contribute to the market's sustained growth. Healthcare providers and manufacturers are actively working on developing innovative solutions to meet the evolving needs of patients with lacrimal disorders, with a focus on improving care quality and patient comfort. Regulatory factors and reimbursement policies also play a significant role in shaping the market's dynamics. Overall, the lacrimal devices market presents promising opportunities for companies in the ophthalmic devices sector, with an increasing emphasis on patient-centred solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lacrimal Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lacrimal Devices Market Segmental Analysis

The global lacrimal devices market is segmented on the basis of product, application and region. Based on product the market is segmented as intubation sets, stents and tubes, dilators. On the basis of application, the market is segmented as glaucoma, dry eye, and lacrimal gland inflammation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Lacrimal Devices Market

The main factor fuelling the lacrimal devices market is the rising prevalence of eye disorders worldwide. Elements such as aging populations, shifting lifestyles, and increased screen usage lead to conditions such as dry eye syndrome and other lacrimal system disorders. This results in an increased need for lacrimal devices for diagnosing and treating these conditions, driving the growth of the market.

Restraints in the Global Lacrimal Devices Market

A significant challenge in the lacrimal devices sector is the strict regulatory environment and potential delays in obtaining approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, have rigorous standards for medical devices, which can result in prolonged timelines for market introduction. These regulatory obstacles can hinder innovation and market expansion, affecting both established companies and new entrants in the field.

Market Trends of the Global Lacrimal Devices Market

A notable trend in the lacrimal devices market is the growing inclination towards minimally invasive procedures. Patients and healthcare providers are favouring less invasive methods for treating lacrimal system disorders due to their advantages, including faster recovery times, fewer postoperative complications, and enhanced patient comfort. This shift is spurring innovation in the creation of minimally invasive lacrimal devices, such as micro endoscopes and specialized catheters, to meet the changing preferences in patient care.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Lacrimal Devices Market by Product

  • Market Overview
  • Intubation Sets
  • Stents And Tubes
  • Dilators

Global Lacrimal Devices Market by Application

  • Market Overview
  • Glaucoma
  • Dry Eye
  • Lacrimal Gland Inflammation

Global Lacrimal Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • FCI Ophthalmic (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kaneka Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lacrimedics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Group (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVI (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rumex International (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bess Medical Technology GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch and Lomb Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BraunMelsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OASIS Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beaver-Visitec International (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FC Optics Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptiMedica Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroSurgical Technology (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diamatrix Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FCI S.A.S. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eye Kon Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제